Evaluation on Inter-Assay Consistency and Inter-Reader Precision for PD-L1 Assays: Ventana SP263 and Dako 22C3 in Non-Small Cell Lung Cancer

被引：1
|
作者：
Lin, D. [1 ]
Yang, X. [1 ]
机构：
[1] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Pathol,Minist Educ, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
PD-L1; Assays; TPS; Non-Small Cell Lung Cancer;
D O I：
10.1016/j.jtho.2019.08.1663
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.09-14
引用
收藏
页码：S774 / S774
页数：1
相关论文
共 50 条
  • [31] Validation studies of PD-L1 IHC 22C3 pharmDx (Dako Omnis) for human non-small cell lung carcinoma (NSCLC) tissues
    Kramer, L.
    Toland, G.
    O'Brien, J.
    Roach, C.
    Welcher, R.
    Kulangara, K.
    VIRCHOWS ARCHIV, 2019, 475 : S139 - S140
  • [32] PD-L1 immunohistochemical expression in bladder urothelial cancer with SP263, SP142 and 22C3 antibodies: A comparative study
    Paliogiannis, Panagiotis
    Lobrano, Renato
    Bella, Michele Angelo
    Fara, Antonella
    Uras, Maria Gabriela
    Pinna, Maria Antonia
    Tedde, Alessandro
    Madonia, Massimo
    Zinellu, Angelo
    Cossu, Antonio
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2024, 69
  • [33] Reproducibility study on non-small cell lung cancer specimens stained with PD-L1 IHC 22C3 pharmDx (Dako Omnis, GE006)
    Musser, J.
    Toland, G.
    Roach, C.
    Tabuena-Frolli, S.
    Hund, S.
    VIRCHOWS ARCHIV, 2024, 485 : S446 - S446
  • [34] Distribution and concordance of PD-L1 expression by routine 22C3 assays in East-Asian patients with non-small cell lung cancer
    Fangqiu Fu
    Chaoqiang Deng
    Wenrui Sun
    Qiang Zheng
    Yan Jin
    Yuan Li
    Yang Zhang
    Haiquan Chen
    Respiratory Research, 23
  • [35] Distribution and concordance of PD-L1 expression by routine 22C3 assays in East-Asian patients with non-small cell lung cancer
    Fu, Fangqiu
    Deng, Chaoqiang
    Sun, Wenrui
    Zheng, Qiang
    Jin, Yan
    Li, Yuan
    Zhang, Yang
    Chen, Haiquan
    RESPIRATORY RESEARCH, 2022, 23 (01)
  • [36] PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs
    Park, Yujun
    Koh, Jiwon
    Na, Hee Young
    Kwak, Yoonjin
    Lee, Keun-Wook
    Ahn, Sang-Hoon
    Park, Do Joong
    Kim, Hyung-Ho
    Lee, Hye Seung
    CANCER RESEARCH AND TREATMENT, 2020, 52 (03): : 661 - 670
  • [37] Heterogeneity assessment of two PD-L1 clones: 22C3 and SP142 in patients with non-small cell lung cancer (NSCLC).
    Xu, Haipeng
    Li, Chao
    Gen, Lin
    Fang, Rong Xi
    Lin, Dong xian
    Huang, Yunjian
    Zhuang, Wu
    Miao, Qian
    Jiang, Kan
    Huang, Cheng
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] Performance of Ventana SP263 PD-L1 assay in endobronchial ultrasound guided-fine-needle aspiration derived non-small-cell lung carcinoma samples
    Chauhan, Aastha
    Siegel, Lianne
    Freese, Rebecca
    Racila, Emilian
    Stewart, Jimmie, III
    Amin, Khalid
    DIAGNOSTIC CYTOPATHOLOGY, 2021, 49 (03) : 355 - 362
  • [39] Inter-tumor Heterogeneity of PD-L1 Expression in Non-small Cell Lung Cancer
    Saito, Y.
    Wakimoto, S.
    Morooka, H.
    Ibi, T.
    Yamauchi, Y.
    Takahashi, N.
    Shimizu, Y.
    Ikeya, T.
    Sakao, Y.
    Kawamura, M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S568 - S569
  • [40] Inter-Tumor Heterogeneity of PD-L1 Expressions in Non-Small Cell Lung Cancer
    Saito, Y.
    Horiuchi, S.
    Morooka, H.
    Ibi, T.
    Takahashi, N.
    Ikeya, T.
    Hoshi, E.
    Shimizu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S461 - S462
12345